Objectives

After participating in this educational activity, attendees should be able to:
1|Identify biological and clinical significance of pancreatic precursor lesions in the progression to invasive cancer.
2|Discuss recent advances in 3D genomic mapping and their contribution to understanding pancreatic precursor lesions and their progression to invasive cancer.
3|Recognize recent advances in the tumor immune microenvironment in precursor lesions and their influence on pancreatic cancer development.

Presenter(s): 
Laura DeLong Wood, MD, PhD
Associate Professor of Pathology, Oncology, & Medicine
Director, Gastrointestinal & Liver Pathology
Deputy Director, Sol Goldman Pancreatic Cancer Research Center
Associate Director, MD/PhD Program
Co-Leader, Cancer Invasion & Metastasis Program
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
 
Kevin Tony Jamouss, MD
Internal Medicine Resident Physician, UMass Chan Medical School-Baystate
Department of Medicine, Baystate Health
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Laura Delong Wood, MD, PhD Speaker No relevant relationships with ineligible companies to discloseno
Kevin Jamouss, MDSpeaker
No relevant relationships with ineligible companies to disclose
no
Session date: 
09/10/2025 - 8:00am to 9:00am EDT
Location: 
Baystate Medical Center
759 Chestnut Street
Webinar only
Springfield, MA 01199
United States
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.